Grandfield & Dodd, LLC Amgen Inc Transaction History

Grandfield & Dodd, LLC

$1.61 Billion
Q2 2025

A detailed history of Grandfield & Dodd, LLC transactions in Amgen Inc stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 8,176 shares of AMGN stock, worth $2.37 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

8,176

Previous 8,018 1.97%

Holding current value

$2.37 Million

Previous $2.5 Million 8.65%

% of portfolio

0.14%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$262.28 - $309.85 $41,440 - $48,956	158 Added 1.97%	8,176 $2.28 Million
Q4 2024 Feb 06, 2025	SELL	$258.78 - $328.31 $71,164 - $90,285	-275 Reduced 3.32%	8,018 $2.09 Million
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $162,424 - $177,124	-525 Reduced 5.95%	8,293 $2.67 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $1,344 - $1,622	5 Added 0.06%	8,818 $2.51 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $122,736 - $138,460	-480 Reduced 5.17%	8,813 $2.54 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $21,865 - $27,145	-100 Reduced 1.06%	9,293 $2.5 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $213,412 - $252,356	-996 Reduced 9.59%	9,393 $2.09 Million
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $173,858 - $211,904	770 Added 8.0%	10,389 $2.51 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $13,512 - $17,169	-59 Reduced 0.61%	9,619 $0
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $157,346 - $177,458	-701 Reduced 6.75%	9,678 $2.18 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $36,452 - $40,564	-158 Reduced 1.5%	10,379 $2.53 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $98,671 - $109,156	-450 Reduced 4.1%	10,537 $2.55 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $210,017 - $240,345	-1,056 Reduced 8.77%	10,987 $2.47 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $248,143 - $290,730	-1,169 Reduced 8.85%	12,043 $2.56 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $79,650 - $88,366	-341 Reduced 2.52%	13,212 $3.22 Million
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $38,168 - $44,479	-172 Reduced 1.25%	13,553 $3.37 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $191,496 - $228,037	-885 Reduced 6.06%	13,725 $3.16 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $168,478 - $187,362	-718 Reduced 4.68%	14,610 $3.71 Million
Q2 2020 Jul 24, 2020	SELL	$197.81 - $242.74 $847,022 - $1.04 Million	-4,282 Reduced 21.84%	15,328 $3.62 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1.84 Million - $2.43 Million	-10,070 Reduced 33.93%	19,610 $3.98 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $85,522 - $109,926	-452 Reduced 1.5%	29,680 $7.16 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $109,166 - $130,804	-627 Reduced 2.04%	30,132 $5.83 Million
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $298,226 - $349,588	-1,789 Reduced 5.5%	30,759 $5.67 Million
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $124,800 - $140,677	-690 Reduced 2.08%	32,548 $6.18 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $186,249 - $217,413	-1,044 Reduced 3.05%	33,238 $6.47 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $276,452 - $311,663	-1,492 Reduced 4.17%	34,282 $7.11 Million
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $329,277 - $369,849	-1,983 Reduced 5.25%	35,774 $6.6 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $196,877 - $230,076	-1,162 Reduced 2.99%	37,757 $6.44 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $384,334 - $429,419	-2,277 Reduced 5.53%	38,919 $6.77 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $6.89 Million - $7.87 Million	41,196	41,196 $7.68 Million

Others Institutions Holding AMGN

# of Institutions

3,278

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Account

Grandfield & Dodd, LLC Amgen Inc Transaction History